Berman Tabacco represents client in this derivative action alleging that certain officers and directors of AmerisourceBergen Corp. breached their fiduciary duties to the company in connection with an illegal scheme to produce and market unapproved prefilled syringes in violation of federal and state laws for which an Amerisource subsidiary pleaded guilty and paid hundreds of millions of dollars in fines and penalties. In 2017, Amerisource entered a guilty plea related to the alleged illegal PFS scheme and has paid more than $875 million in penalties and fines to settle related civil and criminal claims. This action follows a successful action filed pursuant to 8 Del. C. § 220 to compel the company to provide certain of its books and records. In re AmerisourceBergen Corp. Section 200 Litig., C.A. No. 2018-0209 (Del. Ch. Ct.).